Long-term COVID symptoms, work ability and fitness to work in healthcare workers hospitalized for Sars-CoV-2 infection.


Journal

La Medicina del lavoro
ISSN: 0025-7818
Titre abrégé: Med Lav
Pays: Italy
ID NLM: 0401176

Informations de publication

Date de publication:
24 Oct 2022
Historique:
received: 22 06 2022
accepted: 16 09 2022
entrez: 25 10 2022
pubmed: 26 10 2022
medline: 27 10 2022
Statut: epublish

Résumé

COVID-19 can affect the persistence of symptoms and work ability (WA), hence the fitness to work of healthcare workers (HCW). We describe the effects of COVID-19 in hospitalized HCWs of a large Hospital in Lombardy and their implications on WA and fitness to work. Fifty-six HCWs of Fatebenefratelli-Sacco Hospital have been hospitalized for COVID-19 since March 2020. Clinical and fitness-to-work data were acquired from Occupational Health Surveillance Program. A structured questionnaire was administered to 53/56 HCWs 18 months after infection to investigate Long-COVID symptoms and WA. Symptoms most reported at recovery (rhino-pharyngeal swab-NPS-negative) were exertional dyspnea (86.8%), asthenia (86.8%), arthro-myalgia (71.7%), sleep disorders (64.2%), resting dyspnea (62.3%), cough (56.6%). 69.6% underwent evaluation at out-patient clinics experienced in Long-COVID. Ten months after recovery, symptoms related to physical well-being decreased while memory and anxiety/depression were more persistent. At recovery, the WA score decreased from 10 to 8, and then an improvement from 8 to 9 was noted during the survey. At the return-to-work examination, fit-to-work judgements with restrictions increased from 31.4% to 58.7%; then, a slight decrease in the rate of judgements with restrictions was observed at the survey's time. Post-COVID-19 symptoms can persist for a long time and could impact WA and fitness-to-work of HCW. Adequate health surveillance protocols should guarantee the health protection of HCW with persistent disorders after COVID-19.

Sections du résumé

BACKGROUND BACKGROUND
COVID-19 can affect the persistence of symptoms and work ability (WA), hence the fitness to work of healthcare workers (HCW). We describe the effects of COVID-19 in hospitalized HCWs of a large Hospital in Lombardy and their implications on WA and fitness to work.
METHODS METHODS
Fifty-six HCWs of Fatebenefratelli-Sacco Hospital have been hospitalized for COVID-19 since March 2020. Clinical and fitness-to-work data were acquired from Occupational Health Surveillance Program. A structured questionnaire was administered to 53/56 HCWs 18 months after infection to investigate Long-COVID symptoms and WA.
RESULTS RESULTS
Symptoms most reported at recovery (rhino-pharyngeal swab-NPS-negative) were exertional dyspnea (86.8%), asthenia (86.8%), arthro-myalgia (71.7%), sleep disorders (64.2%), resting dyspnea (62.3%), cough (56.6%). 69.6% underwent evaluation at out-patient clinics experienced in Long-COVID. Ten months after recovery, symptoms related to physical well-being decreased while memory and anxiety/depression were more persistent. At recovery, the WA score decreased from 10 to 8, and then an improvement from 8 to 9 was noted during the survey. At the return-to-work examination, fit-to-work judgements with restrictions increased from 31.4% to 58.7%; then, a slight decrease in the rate of judgements with restrictions was observed at the survey's time.
CONCLUSION CONCLUSIONS
Post-COVID-19 symptoms can persist for a long time and could impact WA and fitness-to-work of HCW. Adequate health surveillance protocols should guarantee the health protection of HCW with persistent disorders after COVID-19.

Identifiants

pubmed: 36282031
doi: 10.23749/mdl.v113i5.13377
pmc: PMC9632671
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2022040

Références

Ergonomics. 2007 Nov;50(11):1914-30
pubmed: 17972209
Sleep Med. 2022 Mar;91:237-245
pubmed: 34334303
Nord J Psychiatry. 2002;56(4):261-4
pubmed: 12470316
Med Lav. 2021 Dec 23;112(6):453-464
pubmed: 34939623
Viruses. 2021 Jan 29;13(2):
pubmed: 33572857
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Biomedicines. 2021 Jul 27;9(8):
pubmed: 34440104
JAMA Netw Open. 2021 Jan 4;4(1):e2036142
pubmed: 33502487
BMJ Open. 2021 Sep 2;11(9):e046036
pubmed: 34475149
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Saf Health Work. 2022 Mar;13(1):104-111
pubmed: 34849267
Infection. 2021 Feb;49(1):15-28
pubmed: 32860214
J Infect. 2022 May;84(5):722-746
pubmed: 35077770
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34580069
Lancet Respir Med. 2022 Sep;10(9):863-876
pubmed: 35568052
Ann Am Thorac Soc. 2022 Apr;19(4):551-561
pubmed: 34582728
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178

Auteurs

Marco Mendola (M)

Occupational Health Unit, Fatebenefratelli Sacco University Hospital, Milan. mendola.marco@asst-fbf-sacco.it.

Marco Leoni (M)

School of Occupational Medicine, University of Milan, Milan, Italy. leoni.marco@asst-fbf-sacco.it.

Ylenia Cozzi (Y)

School of Occupational Medicine, University of Milan, Milan, Italy. cozzi.ylenia@asst-fbf-sacco.it.

Andrea Manzari (A)

School of Occupational Medicine, University of Milan, Milan, Italy. manzari.andrea@asst-fbf-sacco.it.

Fabio Tonelli (F)

Occupational Health Unit, Fatebenefratelli Sacco University Hospital, Milan. tonelli.fabio@asst-fbf-sacco.it.

Francesca Metruccio (F)

International Centre for Pesticides and Health Risk Prevention, Fatebenefratelli Sacco University Hospital, Milan. metruccio.francesca@asst-fbf-sacco.it.

Luca Tosti (L)

International Centre for Pesticides and Health Risk Prevention, Fatebenefratelli Sacco University Hospital, Milan. tosti.luca@asst-fbf-sacco.it.

Vera Battini (V)

Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy. vera.battini@unimi.it.

Isabella Cucchi (I)

Occupational Health Unit, Fatebenefratelli Sacco University Hospital, Milan. cucchi.isabella@asst-fbf-sacco.it.

Maria Cristina Costa (MC)

Occupational Health Unit, Fatebenefratelli Sacco University Hospital, Milan. mariacristina.costa@asst-fbf-sacco.it.

Paolo Carrer (P)

Occupational Health Unit, Fatebenefratelli Sacco University Hospital, Milan; Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy. carrer.paolo@asst-fbf-sacco.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH